HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Goeran Hajak Selected Research

Tinnitus

9/2014Feasibility, safety and efficacy of transcutaneous vagus nerve stimulation in chronic tinnitus: an open pilot study.
10/2011Transcranial magnetic stimulation for the treatment of tinnitus: 4-year follow-up in treatment responders--a retrospective analysis.
1/2011Can Temporal Repetitive Transcranial Magnetic Stimulation be Enhanced by Targeting Affective Components of Tinnitus with Frontal rTMS? A Randomized Controlled Pilot Trial.
8/2010The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome.
7/2008Controversy: Does repetitive transcranial magnetic stimulation/ transcranial direct current stimulation show efficacy in treating tinnitus patients?
4/2008Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus.
4/2008Combined temporal and prefrontal transcranial magnetic stimulation for tinnitus treatment: a pilot study.
10/2007Which tinnitus patients benefit from transcranial magnetic stimulation?
4/2005Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Goeran Hajak Research Topics

Disease

9Tinnitus
09/2014 - 04/2005
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 06/2012
3Sleep Deprivation
04/2012 - 03/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
09/2009 - 07/2008
2Epilepsy (Aura)
09/2014 - 01/2012
2Mood Disorders (Mood Disorder)
09/2014 - 01/2012
2Dementia (Dementias)
07/2012 - 09/2006
1Weight Gain
01/2020
1Sleepiness
01/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2020
1Schizophrenia (Dementia Praecox)
07/2013
1Hypothermia
07/2012
1Wounds and Injuries (Trauma)
06/2012
1Major Depressive Disorder (Major Depressive Disorders)
09/2011
1Disorders of Excessive Somnolence (Hypersomnia)
09/2011
1Cataplexy
05/2011
1Noise-Induced Hearing Loss (Acoustic Trauma)
04/2010
1Cognitive Dysfunction
09/2009
1Blindness (Hysterical Blindness)
08/2009
1Chronic Disease (Chronic Diseases)
07/2008

Drug/Important Bio-Agent (IBA)

4Antidepressive Agents (Antidepressants)IBA
04/2012 - 04/2011
1Mirtazapine (Rexer)FDA LinkGeneric
01/2020
1BenperidolIBA
07/2012
1Antipsychotic Agents (Antipsychotics)IBA
07/2012
1Olanzapine (Zyprexa)FDA Link
07/2012
1ORALIT (ORS)IBA
06/2012
15-HT2C Serotonin ReceptorIBA
09/2011
1agomelatine (S20098)IBA
09/2011
1EscitalopramFDA Link
09/2011
1MT2 Melatonin ReceptorIBA
09/2011
1Potassium Channels (Potassium Channel)IBA
04/2010
1AntioxidantsIBA
09/2009
1Monoamine Oxidase (MAO)IBA
05/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2008
1Anthocyanins (Anthocyanin)IBA
07/2008
1Biomarkers (Surrogate Marker)IBA
09/2006
1PlacebosIBA
04/2005
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
03/2005

Therapy/Procedure

10Transcranial Magnetic Stimulation
04/2012 - 04/2005
3Therapeutics
01/2021 - 08/2010
2Vagus Nerve Stimulation
09/2014 - 01/2012
1Occupational Therapy (Therapy, Occupational)
07/2013
1Cognitive Training
07/2013
1Aftercare (After-Treatment)
10/2011
1Implanted Electrodes
07/2008
1Transcranial Direct Current Stimulation
07/2008